Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF) Short Interest Down 6.0% in March

Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF) was the target of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 4,700 shares, a decline of 6.0% from the March 15th total of 5,000 shares. Based on an average trading volume of 7,800 shares, the days-to-cover ratio is presently 0.6 days.

Eupraxia Pharmaceuticals Stock Down 3.0 %

Shares of OTCMKTS EPRXF opened at C$2.62 on Thursday. Eupraxia Pharmaceuticals has a 1 year low of C$2.93 and a 1 year high of C$6.78. The stock’s 50-day simple moving average is C$4.00 and its 200-day simple moving average is C$4.15.

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.